A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort
Loreta A Kondili,Giuseppina Brancaccio,Maria Elena Tosti,Barbara Coco,Maria Giovanna Quaranta,Vincenzo Messina,Alessia Ciancio,Filomena Morisco,Valentina Cossiga,Ernesto Claar,Valerio Rosato,Marianna Ciarallo,Irene Cacciola,Francesca Romana Ponziani,Lucia Cerrito,Roberta Coppola,Francesco Longobardi,Elisa Biliotti,Alessia Rianda,Francesco Barbaro,Nicola Coppola,Maria Stanzione,Francesco Barchiesi,Stefano Fagiuoli,Mauro Viganò,Marco Massari,Francesco Paolo Russo,Alberto Ferrarese,Diletta Laccabue,Vito Di Marco,Pierluigi Blanc,Aldo Marrone,Giulia Morsica,Alessandro Federico,Donatella Ieluzzi,Alba Rocco,Francesco Giuseppe Foschi,Alessandro Soria,Ivana Maida,Luchino Chessa,Michele Milella,Elena Rosselli Del Turco,Salvatore Madonia,Liliana Chemello,Ivan Gentile,Pierluigi Toniutto,Matteo Bassetti,Lorenzo Surace,Leonardo Baiocchi,Adriano Pellicelli,Adriano De Santis,Massimo Puoti,Elisabetta Degasperi,Grazia Anna Niro,Anna Linda Zignego,Antonio Craxi,Giovanni Raimondo,Teresa Antonia Santantonio,Maurizia Rossana Brunetto,Giovanni Battista Gaeta,PITER Collaborating Investigators,Alessio Aghemo,Chiara Baiguera,Pier Maria Battezzati,Sara Battistella,Maria Grazia Bavetta,Costanza Bertoni,Carolina Boni,Paola Brambilla,Antonella Bray,Federica Briano,Enrico Carmenini,Francesco Castelli,Luisa Cavalletto,Federica Cerini,Luciana Chidichimo,Elisa Colella,Giuliana Cologni,Silvia Como,Romina Corsini,Chiara Costa,Rosa Cotugno,Silvia Cretella,Fernando De Angelis,Pasqualina De Leo,Giovanni Di Perri,Elisabetta Falbo,Luigina Ferrigno,Ezio Fornasiere,Daniela Francisci,Pietro Gatti,Pietro Lampertico,Ilaria Lenci,Anna Licata,Alfredo Marzano,Antonio Mastroianni,Cesare Mazzaro,Monica Monti,Gerardo Nardone,Laura Ambra Nicolini,Nicola Passigato,Maria Bruna Pasticci,Piera Pierotti,Biagio Pinchera,Teresa Pollicino,Carmen Porcu,Giulia Quartini,Gabriele Rancatore,Mario Romeo,Maria Grazia Rumi,Annalisa Saracino,Ornella Schioppa,Ilaria Serio,Roberta Soffredini,Xhimi Tata,Marco Tizzani,Matteo Tonnini,Carlo Torti,Daniela Valenti,Serena Zaltron,Alessia Zoncada
DOI: https://doi.org/10.1016/j.ijid.2024.107115
Abstract:Background and aims: We aimed to characterize the epidemiologic and comorbidities profiles of patients with chronic Hepatitis D (CHD) followed in clinical practice in Italy and explored their interferon (IFN) eligibility. Methods: This was a cross-sectional study of the PITER cohort consisting of consecutive HBsAg-positive patients from 59 centers over the period 2019-2023. Multivariable analysis was performed by logistic regression model. Results: Of 5492 HBsAg-positive enrolled patients, 4152 (75.6%) were screened for HDV, 422 (10.2%) were anti-HDV positive. Compared with HBsAg mono-infected, anti-HDV positive patients were more often younger, non-Italians, with a history of drug use, had elevated alanine transaminase (ALT), cirrhosis, or hepatocellular carcinoma (HCC). Compared with Italians, anti-HDV positive non-Italians were younger (42.2% age ≤ 40 years vs. 2.1%; P < 0.001), more often females (males 43.0% vs. 68.6%; P < 0.001) with less frequent cirrhosis and HCC. HDV-RNA was detected in 63.2% of anti-HDV-positive patients, who were more likely to have elevated ALT, cirrhosis, and HCC. Extrahepatic comorbidities were present in 47.4% of anti-HDV positive patients and could affect the eligibility of IFN-containing therapies in at least 53.0% of patients in care. Conclusions: CHD affects young, foreign-born patients and older Italians, of whom two-thirds had cirrhosis or HCC. Comorbidities were frequent in both Italians and non-Italians and impacted eligibility for IFN.